Highlights:
- Stock Performance: Lovisa shares dropped 7% in early trade, compounding a 9% decline over the past month.
- Broker Downgrades: UBS and Jefferies downgraded Lovisa this week, lowering the stock’s consensus rating from "buy" to "hold."
- Competitor Developments: Former Lovisa CEO Shane Fallscheer, now leading rival Harli + Harpa, faces a lawsuit, raising concerns about competitive pressure.
Lovisa Holdings Ltd (ASX:LOV), an ASX 200-listed fashion jewelry retailer, experienced a sharp sell-off in early trading on Thursday. The stock fell 7% to AU$27.78, briefly hitting an intraday low of AU$27.46, marking an 8.3% drop. This continues a broader downtrend for Lovisa, with shares sliding nearly 9% over the past month.
While no price-sensitive announcements were made this morning, the decline coincides with broker downgrades and reports of a lawsuit involving the company’s former CEO, now heading a competitor.
Broker Downgrades Hit Lovisa
Several brokers revised their outlook on Lovisa this week, contributing to the stock’s downward momentum. UBS downgraded the stock to "sell," while Jefferies adjusted its recommendation from "buy" to "hold."
As a result, the consensus analyst rating for Lovisa has shifted from a "buy" to a "hold."
However, not all analysts are bearish. Morgans remains optimistic, maintaining a "buy" rating with a price target of AU$36.50. Morgans expressed confidence in Lovisa’s ability to expand its brand globally, stating the company can "successfully build out its unique brand in many diverse territories."
Despite today’s slump, Lovisa shares have gained 19% over the past year, reflecting broader confidence in the company’s growth potential.
Lawsuit Involving Former CEO
Adding to the unease, reports surfaced today about a lawsuit involving Shane Fallscheer, Lovisa’s former CEO and now the head of rival jewelry chain Harli + Harpa.
According to The Australian, former Harli + Harpa CEO Cass Fuller has filed legal proceedings against Fallscheer, alleging wrongful dismissal.
While this lawsuit does not directly involve Lovisa, Harli + Harpa has emerged as a notable competitor. The rival chain has opened 18 stores since November 2023, potentially challenging Lovisa’s market position.
Analysts at Citi noted the competitor’s rapid expansion, stating:
"Given Lovisa has 178 stores in Australia (as of FY24), the impact on Lovisa's earnings to date is likely immaterial. However, the rapid pace of openings for Harli + Harpa raises concerns about Lovisa's sales and margins in CY25 and possibly sooner in H1 FY25."
Broader Context
Lovisa’s stock has been in a broader decline since peaking at AU$36.19 in mid-October. The combination of broker downgrades, concerns about rising competition, and the ongoing downtrend has driven investor caution.